Mar 28, 2021 by Jason Hawthorne3 Unstoppable Stocks to Buy in This Bull MarketEven if the bullishness fades, the prospects for these companies have never been better.
Mar 27, 2021 by Jason HawthorneForget Altria: Here Are 3 Better Dividend StocksConsidering business quality is the best way to earn growing payouts over time.
Mar 27, 2021 by Jason HawthorneBuy These 3 Stocks In Any Stock Market CrashThey were able to keep growth going despite the pandemic.
Mar 25, 2021 by Jason Hawthorne3 Top Biotech Stocks for Spring 2021Though these stocks have dropped, upcoming news offers hope for them to rebound.
Mar 24, 2021 by Jason Hawthorne2 Potential 10-Bagger Stocks Cathie Wood and ARK Don't Own YetIf you are following the crowd, you might miss these disruptive companies.
Mar 21, 2021 by Jason Hawthorne2 Cathie Wood Stocks That Are 40% OffThese companies may represent the future, but their stocks are getting pummeled in the present.
Mar 19, 2021 by Jason Hawthorne1 Stock Warren Buffett and Cathie Wood Have in Common and 1 They ShouldDigging into the popular investors' portfolios teaches us to look beyond Wall Street labels.
Mar 18, 2021 by Jason Hawthorne1 Number Every Teladoc Investor Should Pay Attention ToThe source of growth will need to shift for the company to keep its promises.
Mar 17, 2021 by Jason HawthorneWhy I'll Never Own Tesla StockThe electric vehicle maker may represent the future of transportation, but a couple of factors are holding me back.
Mar 17, 2021 by Jason HawthorneThis Is Why Teladoc Is a Great Stock to Buy Right NowThe market is offering a rare discount just as uncertainty is clearing up.
Mar 14, 2021 by Jason HawthorneShould You Buy Fulgent Genetics Stock in March?Despite tremendous growth, the stock is cheap based on at least one common Wall Street metric.
Mar 14, 2021 by Jason HawthorneIs Inari Medical a Buy?The clot-removing device maker is nearly perfect, and it's priced like it.
Mar 13, 2021 by Jason Hawthorne2 Green Flags and 1 Red Flag From Teladoc's EarningsDespite impressive growth, the worry over one number is actually presenting investors with a long-awaited opportunity.
Mar 13, 2021 by Jason HawthorneTeladoc's CEO Just Explained Why the Livongo Merger Is a WinnerDespite hitting all of its goals for integration, the company is as cheap as it has been since before the pandemic.
Mar 7, 2021 by Jason HawthorneThis Is the Stock Warren Buffett Should Have Been BuyingThis unlikely choice meets several of his criteria.
Mar 6, 2021 by Jason Hawthorne1 Question I'm Trying to Answer About Riot BlockchainThe answer might make you think twice about buying shares.
Mar 6, 2021 by Jason HawthorneIs Clover Health Stock a Buy?It depends on whether providers are willing to sign up for lower costs and better outcomes.
Mar 6, 2021 by Jason HawthorneWhere Will Vaxart Be in 1 Year?A flaw in the logic behind a big sell-off may lead to a big surprise sometime in 2021.
Mar 5, 2021 by Jason HawthorneWhat's the Outlook for Intuitive Surgical?Competition is heating up, but the company's market leadership remains unchallenged.
Mar 5, 2021 by Jason HawthorneIs BioNTech Stock a Buy?The key ingredients are here for a multi-bagger over the next decade and beyond.
